Gene Editing Company Takes Off in Premarket

Post a Comment
Trade of the Day Wake-Up Watchlist

Good morning Wake-Up Watchlisters! It's the beginning of the week, and our Lead Technical Tactician Nate Bear is giving you his weekly stocks to watch. Right now he's got his eye on two potential trade setups, plus some thoughts on the SPX. Click the image below to see this week's stocks.


While you're sipping coffee you'll see US futures dipped on Tuesday. Earnings season is underway, and investors will be focusing on megabanks like Goldman Sachs (GS) and Morgan Stanley (MS). Also, Global leaders will be gathering in the mountains of Davos, Switzerland this week for the World Economic Forum, with the prospect of global recession a major topic.

Earnings season is here, and it's crucial to use the best practices if you want to make gains in the market. We have a strategy in The War Room that's proven to help members double their money (or more) in 24 hours – regardless of whether a stock goes up or down.

Click here to learn how you could 2x your money overnight.


Here's a look at the top-moving stocks this morning.

National Instruments Corporation (Nasdaq: NATI)

National Instruments Corporation is up 11.77% premarket after it was announced that Emerson (NYSE: EMR) submitted a proposal to acquire NI for $53 per share in cash at an implied value of $7.6 billion. The proposal represents an improvement over an initial $48 per share and will provide immediate cash value for all NI shareholders.


Calyxt, Inc. (Nasdaq: CLXT)

Calyxt Inc. is up 62.09% premarket after the technology platform announced a merger with Cibus, with the goal to create an industry-leading gene editing and trait licensing company. The merger will establish one of the world's most sophisticated facilities for trait development and next-generation plant breeding.

We're on the cusp of the next big tech revolution, and our friend Andy Snyder wants you to know about this up-and-coming virtual company. He believes this fully immersive service could be front and center of the next big tech boom, and right now it's trading for less than $1.

Click here to unlock this innovative company.


Have You Heard of the 44/52 Guarantee?

Frustrated Older Man at Computer

Renegade market experts just rocked the financial world...

It's a shocking 44/52 guarantee offer... and it's unprecedented.

See How the 44/52 Guarantee Could Change Your Portfolio

Viveve Medical (Nasdaq: VIVE)

Viveve Medical is down 56.98 % premarket after the women's health and treatment of female stress urinary incontinence's latest PURSUIT study did not meet its primary endpoint of achieving a statistically significant higher proportion who experienced greater than 50% reduction in urine leakage compared to the baseline. The proportion of patients with over a 50% reduction in leakage in the active group was 49.8%.

A breakthrough medical company can see huge surges in stock price when it delivers results. Our friend Alexander Green has a proven track record of finding these buying opportunities, and right now he's pounding the table on a $3 company he's calling the "most incredible investment opportunity I've seen in 37 years."

Click here to learn more about this potential game-changing medical device.


Those are the top market movers today.

Happy trading!

The Wake-Up Watchlist Research Team

URGENT PRICE UPDATE: Wall Street Projects $30 Stock to Move to $280 in 18 Months.

Consensus Target Price

The spiraling European energy crisis has a silver lining... Wall Street says it could drive one stock from $30 to $280 in just 18 months. Find out why right here.

Related Posts

There is no other posts in this category.

Post a Comment

Subscribe Our Newsletter